Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ChromaDex Co. stock logo
CDXC
ChromaDex
$3.22
+9.2%
$2.74
$1.25
$4.65
$242.50M1.98260,397 shs118,698 shs
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$11.55
+0.9%
$11.78
$9.63
$12.43
N/AN/A81,686 shs8,408 shs
Tilray Inc stock logo
TLRY
Tilray
$1.80
+4.4%
$1.95
$1.50
$3.40
$1.39B2.3629.15 million shs7.29 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ChromaDex Co. stock logo
CDXC
ChromaDex
-20.05%-24.94%-17.13%+116.91%+110.71%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
-0.17%+1.25%-4.58%+2.15%+4.19%
Tilray Inc stock logo
TLRY
Tilray
-0.58%-3.37%-25.54%-15.27%-25.22%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ChromaDex Co. stock logo
CDXC
ChromaDex
3.5857 of 5 stars
3.52.00.04.12.00.80.6
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
1.382 of 5 stars
3.12.00.00.02.30.01.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ChromaDex Co. stock logo
CDXC
ChromaDex
3.00
Buy$5.8782.19% Upside
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
2.25
Hold$2.7150.88% Upside

Current Analyst Ratings

Latest TLRY, RIV, and CDXC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Tilray Inc stock logo
TLRY
Tilray
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$4.25 ➝ $4.00
4/10/2024
Tilray Inc stock logo
TLRY
Tilray
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.25 ➝ $2.00
4/9/2024
ChromaDex Co. stock logo
CDXC
ChromaDex
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.25 ➝ $6.00
4/5/2024
Tilray Inc stock logo
TLRY
Tilray
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral$2.25 ➝ $2.75
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ChromaDex Co. stock logo
CDXC
ChromaDex
$83.57M2.90N/AN/A$0.38 per share8.47
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$-5.45MN/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
$627.12M2.22N/AN/A$5.07 per share0.35

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ChromaDex Co. stock logo
CDXC
ChromaDex
-$4.94M-$0.07N/A53.67N/A-5.91%-17.81%-9.17%5/8/2024 (Estimated)
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
-$1.45B-$0.44N/AN/AN/A-43.98%-2.68%-2.09%7/24/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ChromaDex Co. stock logo
CDXC
ChromaDex
N/AN/AN/AN/AN/A
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$1.5313.25%-10.79%N/A1 Years
Tilray Inc stock logo
TLRY
Tilray
N/AN/AN/AN/AN/A

Latest TLRY, RIV, and CDXC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/4/2024
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
monthly$0.128912.9%6/14/20246/14/20246/28/2024
4/3/2024
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
monthly$0.128912.9%5/14/20245/15/20245/31/2024
4/1/2024
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
Monthly$0.128912.89%5/14/20245/15/20245/31/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ChromaDex Co. stock logo
CDXC
ChromaDex
N/A
2.40
1.70
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
0.11
1.92
1.18

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ChromaDex Co. stock logo
CDXC
ChromaDex
15.41%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/A
Tilray Inc stock logo
TLRY
Tilray
9.35%

Insider Ownership

CompanyInsider Ownership
ChromaDex Co. stock logo
CDXC
ChromaDex
10.57%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/A
Tilray Inc stock logo
TLRY
Tilray
0.68%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ChromaDex Co. stock logo
CDXC
ChromaDex
10675.31 million67.35 millionOptionable
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/ANot Optionable
Tilray Inc stock logo
TLRY
Tilray
1,600774.03 million768.77 millionOptionable

TLRY, RIV, and CDXC Headlines

SourceHeadline
Tilray (NASDAQ:TLRY) Stock Price Down 3.2%Tilray (NASDAQ:TLRY) Stock Price Down 3.2%
marketbeat.com - April 22 at 2:53 PM
Tilray (NASDAQ:TLRY)  Shares Down 0.3% Tilray (NASDAQ:TLRY) Shares Down 0.3%
americanbankingnews.com - April 21 at 5:12 AM
Tilray (NASDAQ:TLRY) Stock Price Up 3.8%Tilray (NASDAQ:TLRY) Stock Price Up 3.8%
marketbeat.com - April 18 at 3:41 PM
Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider FoundationMontauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation
finance.yahoo.com - April 18 at 9:57 AM
Montauk Brewings Project 4:20 IPA Returns to Support Surfrider FoundationMontauk Brewing's Project 4:20 IPA Returns to Support Surfrider Foundation
globenewswire.com - April 18 at 8:00 AM
Latest News for Tilray Brands Stock (NASDAQ:TLRY)Latest News for Tilray Brands Stock (NASDAQ:TLRY)
benzinga.com - April 18 at 4:56 AM
Tilray (NASDAQ:TLRY) Trading Down 4.9%Tilray (NASDAQ:TLRY) Trading Down 4.9%
marketbeat.com - April 17 at 1:11 PM
The Best Cannabis Stock to Invest $1,000 in Right NowThe Best Cannabis Stock to Invest $1,000 in Right Now
fool.com - April 17 at 7:45 AM
Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The CountryTilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country
finance.yahoo.com - April 17 at 7:32 AM
Whats Going On With Marijuana Grower Tilrays Stock?What's Going On With Marijuana Grower Tilray's Stock?
msn.com - April 16 at 4:10 PM
Tilray (NASDAQ:TLRY) Trading Up 2%Tilray (NASDAQ:TLRY) Trading Up 2%
marketbeat.com - April 16 at 2:58 PM
April 2024s Hot Picks: Top Canadian Cannabis Stocks To Watch NowApril 2024's Hot Picks: Top Canadian Cannabis Stocks To Watch Now
marijuanastocks.com - April 16 at 9:00 AM
Tilray Brands Missed on Revenue in Q3, but This Is the More Concerning Number for InvestorsTilray Brands Missed on Revenue in Q3, but This Is the More Concerning Number for Investors
fool.com - April 16 at 7:15 AM
3 Cannabis Penny Stocks to Buy for 3-Bagger Returns3 Cannabis Penny Stocks to Buy for 3-Bagger Returns
investorplace.com - April 16 at 6:45 AM
Tilray (NASDAQ:TLRY) Trading Up 0.8%Tilray (NASDAQ:TLRY) Trading Up 0.8%
marketbeat.com - April 15 at 3:58 PM
3 Pot Stocks That Could Make You a Cannabis Millionaire3 Pot Stocks That Could Make You a Cannabis Millionaire
investorplace.com - April 15 at 11:20 AM
FY2024 Earnings Estimate for Tilray Inc Issued By Roth Capital (NASDAQ:TLRY)FY2024 Earnings Estimate for Tilray Inc Issued By Roth Capital (NASDAQ:TLRY)
americanbankingnews.com - April 15 at 1:34 AM
Tilray (NASDAQ:TLRY) Trading Down 0.5%Tilray (NASDAQ:TLRY) Trading Down 0.5%
americanbankingnews.com - April 14 at 4:36 AM
FY2024 Earnings Estimate for Tilray Inc (NASDAQ:TLRY) Issued By Alliance Global PartnersFY2024 Earnings Estimate for Tilray Inc (NASDAQ:TLRY) Issued By Alliance Global Partners
americanbankingnews.com - April 13 at 2:54 AM
Analysts Set Tilray Inc (NASDAQ:TLRY) Target Price at $2.88Analysts Set Tilray Inc (NASDAQ:TLRY) Target Price at $2.88
americanbankingnews.com - April 13 at 2:00 AM
Tilray (NASDAQ:TLRY)  Shares Down 0.5% Tilray (NASDAQ:TLRY) Shares Down 0.5%
marketbeat.com - April 12 at 2:50 PM
Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around?Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around?
finance.yahoo.com - April 12 at 1:47 PM
Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around?Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around?
investors.com - April 12 at 10:08 AM
These Marijuana Stocks Could Begin To Rise Again?These Marijuana Stocks Could Begin To Rise Again?
marijuanastocks.com - April 12 at 9:10 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ChromaDex logo

ChromaDex

NASDAQ:CDXC
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
RiverNorth Opportunities Fund logo

RiverNorth Opportunities Fund

NYSE:RIV
RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.
Tilray logo

Tilray

NASDAQ:TLRY
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.